organization · Reporting owner
THOMA BRAVO FUND XII AIV, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
McAfee Corp.
Report date March 01, 2022 · Filed March 04, 2022
Jointly reported with THOMA BRAVO UGP, LLC, THOMA BRAVO PARTNERS XII AIV, L.P., THOMA BRAVO FUND XII-A, L.P., THOMA BRAVO EXECUTIVE FUND XII AIV, L.P., THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P., THOMA BRAVO PARTNERS XII, L.P.
Section 16 reporting ended · disclosed 2022-03-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Explanation of Responses | 0 |
Last balance in matching sequence
After 2022-03-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2022-03-01 · Conversion · Acquired 24,075,115 · Balance 40,686,250 F2: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Row 2 · 2022-03-01 · Other · Disposed 40,686,250 · Balance 0 F4: Consists of Class A Shares that were directly held by TB Partners XII AIV, Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV (collectively, the "TB Funds"). F1: The securities reported herein were disposed of pursuant to the Agreement and Plan of Merger, dated as of November 5, 2021 (the "Merger Agreement"), by and among McAfee Corp. (the "Issuer"), Condor BidCo, Inc. ("Parent"), and Condor Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Subsidiary"), whereby the Merger Subsidiary merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time") on March 1, 2022, each share of Class A common stock (a "Class A Share") of the Issuer outstanding immediately prior to the Effective Time was automatically converted into the right to receive $26.00 in cash, subject to applicable withholding taxes. F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
| Class A Unit and Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Explanation of Responses | 0 |
Reported balance
After 2022-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-01 · Conversion · Disposed 24,075,115 · Balance 0 F2: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities reported herein were disposed of pursuant to the Agreement and Plan of Merger, dated as of November 5, 2021 (the "Merger Agreement"), by and among McAfee Corp. (the "Issuer"), Condor BidCo, Inc. ("Parent"), and Condor Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Subsidiary"), whereby the Merger Subsidiary merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time") on March 1, 2022, each share of Class A common stock (a "Class A Share") of the Issuer outstanding immediately prior to the Effective Time was automatically converted into the right to receive $26.00 in cash, subject to applicable withholding taxes.
F2: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).
F3: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.
F4: Consists of Class A Shares that were directly held by TB Partners XII AIV, Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV (collectively, the "TB Funds").
F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.
F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 4, 2022 11:55 UTC | McAfee Corp. MCFE · Entity 11636 | ConversionClass A Unit and Class B Common Stock · Derivative | 24,075,115 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-009345 · doc4.xml · derivative · entry 3 THOMA BRAVO UGP, LLC · CIK 0001813487 · Former 10% Owner THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · Former 10% Owner THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · Former 10% Owner THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · Former 10% Owner THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · Former 10% Owner THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · Former 10% Owner THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 0 Underlying: Class A Common Stock · 24,075,115 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · derivative.exercise_price: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F2 · price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · price: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F2 · derivative.exercise_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · derivative.exercise_date: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F2 · derivative.expiration_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · derivative.expiration_date: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 11:55 UTC | McAfee Corp. MCFE · Entity 11636 | OtherClass A Common Stock | 40,686,250 | $26.00 | $1,057,842,500.00 |
DisclosureSEC source: 0000899243-22-009345 · doc4.xml · nonDerivative · entry 2 THOMA BRAVO UGP, LLC · CIK 0001813487 · Former 10% Owner THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · Former 10% Owner THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · Former 10% Owner THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · Former 10% Owner THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · Former 10% Owner THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · Former 10% Owner THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 0 F4 · shares: Consists of Class A Shares that were directly held by TB Partners XII AIV, Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV (collectively, the "TB Funds"). F1 · price: The securities reported herein were disposed of pursuant to the Agreement and Plan of Merger, dated as of November 5, 2021 (the "Merger Agreement"), by and among McAfee Corp. (the "Issuer"), Condor BidCo, Inc. ("Parent"), and Condor Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Subsidiary"), whereby the Merger Subsidiary merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time") on March 1, 2022, each share of Class A common stock (a "Class A Share") of the Issuer outstanding immediately prior to the Effective Time was automatically converted into the right to receive $26.00 in cash, subject to applicable withholding taxes. F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 11:55 UTC | McAfee Corp. MCFE · Entity 11636 | ConversionClass A Common Stock | 24,075,115 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-009345 · doc4.xml · nonDerivative · entry 1 THOMA BRAVO UGP, LLC · CIK 0001813487 · Former 10% Owner THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · Former 10% Owner THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · Former 10% Owner THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · Former 10% Owner THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · Former 10% Owner THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · Former 10% Owner THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 40,686,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · shares: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F2 · price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · price: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis. F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 16:30 UTC | McAfee Corp. MCFE · Entity 11636 | OtherClass A Unit and Class B Common Stock · Derivative | 470,263 | $18.90 | $8,887,970.70 |
DisclosureSEC source: 0000899243-20-029508 · doc4.xml · derivative · entry 2 THOMA BRAVO UGP, LLC · CIK 0001813487 · 10% owner THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · 10% owner THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · 10% owner THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · 10% owner THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · 10% owner THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 24,264,482 Underlying: Class A Common Stock · 470,263 shares Expires not disclosed F3 · derivative.exercise_price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F4 · kind: On October 26, 2020, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV sold an aggregate of 470,263 Common Units (together with an equal number of Class B Shares) to the Issuer at a price of $18.90 per Common Unit/Class B Share. F3 · derivative.exercise_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F3 · derivative.expiration_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F2 · ownership.nature: Consists of 2,364,188 Class A units ("Common Units") of Foundation Technology Worldwide LLC directly held by TB Partners XII AIV, 21,502,869 Common Units directly held by TB Fund XII AIV, 210,435 Common Units directly held by TB Exec Fund XII AIV and 186,990 Common Units directly held by TB Exec Fund XII-a AIV, in each case, together with an equal number of shares of Class B Common Stock ("Class B Shares") of the Issuer. F3 · ownership.nature: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares). F4 · ownership.nature: On October 26, 2020, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV sold an aggregate of 470,263 Common Units (together with an equal number of Class B Shares) to the Issuer at a price of $18.90 per Common Unit/Class B Share. F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the securities reported herein held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. F7 · ownership.nature: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 16:30 UTC | McAfee Corp. MCFE · Entity 11636 | SaleClass A Common Stock | 408,340 | $18.90 | $7,717,626.00 |
DisclosureSEC source: 0000899243-20-029508 · doc4.xml · nonDerivative · entry 1 THOMA BRAVO UGP, LLC · CIK 0001813487 · 10% owner THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · 10% owner THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · 10% owner THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · 10% owner THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · 10% owner THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 18,852,120 F1 · ownership.nature: Consists of 71,344 shares of Class A common stock ("Class A Shares") of McAfee Corp. (the "Issuer") directly held by Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), 17,603,384 Class A Shares directly held Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 1,156,028 Class A Shares directly held by Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), 11,312 Class A Shares directly held by Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and 10,052 Class A Shares directly held by Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV" and, collectively with each of the foregoing, the "TB Funds"). F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the securities reported herein held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. F7 · ownership.nature: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.